Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Beatriz G de la Torre

Showing results (1-10 of 192) with videos related to

Pageof 20
Sort By:
Molecules (Basel, Switzerland)|May 17, 2020
Peptide Therapeutics 2.0Beatriz G de la Torre, Fernando Albericio
Journal of Peptide Science : an Official Publication of the European Peptide Society|November 22, 2007
On choosing the right ether for peptide precipitation after acid cleavageBeatriz G de La Torre, David Andreu
Molecules (Basel, Switzerland)|February 14, 2020
The Pharmaceutical Industry in 2019. An Analysis of FDA Drug Approvals from the Perspective of MoleculesBeatriz G de la Torre, Fernando Albericio
Methods and Protocols|November 22, 2022
Practical Protocols for Solid-Phase Peptide Synthesis 4.0Beatriz G de la Torre, Fernando Albericio
Molecules (Basel, Switzerland)|March 8, 2017
The Pharmaceutical Industry in 2016. An Analysis of FDA Drug Approvals from a Perspective of the Molecule TypeBeatriz G de la Torre, Fernando Albericio
Molecules (Basel, Switzerland)|February 13, 2025
The Pharmaceutical Industry in 2024: An Analysis of the FDA Drug Approvals from the Perspective of MoleculesBeatriz G de la Torre, Fernando Albericio
Molecules (Basel, Switzerland)|February 15, 2022
The Pharmaceutical Industry in 2021. An Analysis of FDA Drug Approvals from the Perspective of MoleculesBeatriz G de la Torre, Fernando Albericio
Bioorganic & Medicinal Chemistry Letters|February 5, 2003
Synthesis of labelled PNA oligomers by a post-synthetic modification approachBeatriz G de la Torre, Ramon Eritja
Molecules (Basel, Switzerland)|February 11, 2023
The Pharmaceutical Industry in 2022: An Analysis of FDA Drug Approvals from the Perspective of MoleculesBeatriz G de la Torre, Fernando Albericio
Molecules (Basel, Switzerland)|March 3, 2018
The Pharmaceutical Industry in 2017. An Analysis of FDA Drug Approvals from the Perspective of MoleculesBeatriz G de la Torre, Fernando Albericio
Pageof 20

Showing results (1-10 of 192) with videos related to

Sort By:
Pageof 20
Molecules (Basel, Switzerland)|May 17, 2020
Peptide Therapeutics 2.0Beatriz G de la Torre, Fernando Albericio
Journal of Peptide Science : an Official Publication of the European Peptide Society|November 22, 2007
On choosing the right ether for peptide precipitation after acid cleavageBeatriz G de La Torre, David Andreu
Molecules (Basel, Switzerland)|February 14, 2020
The Pharmaceutical Industry in 2019. An Analysis of FDA Drug Approvals from the Perspective of MoleculesBeatriz G de la Torre, Fernando Albericio
Methods and Protocols|November 22, 2022
Practical Protocols for Solid-Phase Peptide Synthesis 4.0Beatriz G de la Torre, Fernando Albericio
Molecules (Basel, Switzerland)|March 8, 2017
The Pharmaceutical Industry in 2016. An Analysis of FDA Drug Approvals from a Perspective of the Molecule TypeBeatriz G de la Torre, Fernando Albericio
Molecules (Basel, Switzerland)|February 13, 2025
The Pharmaceutical Industry in 2024: An Analysis of the FDA Drug Approvals from the Perspective of MoleculesBeatriz G de la Torre, Fernando Albericio
Molecules (Basel, Switzerland)|February 15, 2022
The Pharmaceutical Industry in 2021. An Analysis of FDA Drug Approvals from the Perspective of MoleculesBeatriz G de la Torre, Fernando Albericio
Bioorganic & Medicinal Chemistry Letters|February 5, 2003
Synthesis of labelled PNA oligomers by a post-synthetic modification approachBeatriz G de la Torre, Ramon Eritja
Molecules (Basel, Switzerland)|February 11, 2023
The Pharmaceutical Industry in 2022: An Analysis of FDA Drug Approvals from the Perspective of MoleculesBeatriz G de la Torre, Fernando Albericio
Molecules (Basel, Switzerland)|March 3, 2018
The Pharmaceutical Industry in 2017. An Analysis of FDA Drug Approvals from the Perspective of MoleculesBeatriz G de la Torre, Fernando Albericio
Pageof 20